Pamuk ON et al. |
Are Turkish Helicobacter pylori strains gaining resistance against clarithromycin? |
2000 |
Am. J. Gastroenterol. |
pmid:10926000
|
al-Assi MT et al. |
Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. |
1994 |
Am. J. Gastroenterol. |
pmid:8053435
|
Take S et al. |
Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection. |
2003 |
Am. J. Gastroenterol. |
pmid:14638340
|
de Bortoli N et al. |
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. |
2007 |
Am. J. Gastroenterol. |
pmid:17313499
|
Mohar A et al. |
Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure. |
2002 |
Am. J. Gastroenterol. |
pmid:12385434
|
De Francesco V et al. |
Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia? |
2002 |
Am. J. Gastroenterol. |
pmid:12385470
|
Chey WD and Wong BC |
American College of Gastroenterology guideline on the management of Helicobacter pylori infection. |
2007 |
Am. J. Gastroenterol. |
pmid:17608775
|
Uygun A et al. |
Low efficacy of ranitidine bismuth citrate plus clarithromycin combination on Helicobacter pylori in a Turkish population. |
1999 |
Am. J. Gastroenterol. |
pmid:10520880
|
Cremonini F et al. |
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. |
2002 |
Am. J. Gastroenterol. |
pmid:12425542
|
Froehlich F et al. |
Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. |
2001 |
Am. J. Gastroenterol. |
pmid:11513170
|
Sánchez-Delgado J et al. |
Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice. |
2008 |
Am. J. Gastroenterol. |
pmid:18564109
|
Hansen JM et al. |
Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study. |
2008 |
Am. J. Gastroenterol. |
pmid:18445098
|
Watson JB and Moss SF |
Will H. pylori stagger under the weight of this LOAD? A novel but expensive eradication regimen. |
2011 |
Am. J. Gastroenterol. |
pmid:22056576
|
Sapone A et al. |
The clinical role of cytochrome p450 genotypes in Helicobacter pylori management. |
2003 |
Am. J. Gastroenterol. |
pmid:12809821
|
Sharma VK et al. |
A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection. |
1999 |
Am. J. Gastroenterol. |
pmid:10566709
|
Levy M et al. |
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. |
2002 |
Am. J. Gastroenterol. |
pmid:11866264
|
Christopher K et al. |
Clarithromycin use preceding fulminant hepatic failure. |
2002 |
Am. J. Gastroenterol. |
pmid:11866297
|
Suzuki S et al. |
The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy. |
2016 |
Am. J. Gastroenterol. |
pmid:27185079
|
Ali' A et al. |
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment. |
1999 |
Am. J. Gastroenterol. |
pmid:10445583
|
Vakil N et al. |
Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. |
1998 |
Am. J. Gastroenterol. |
pmid:9732920
|
Chu KM et al. |
A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori. |
1998 |
Am. J. Gastroenterol. |
pmid:9732921
|
Lamouliatte H et al. |
Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study. |
1998 |
Am. J. Gastroenterol. |
pmid:9732938
|
Sullivan B et al. |
Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. |
2002 |
Am. J. Gastroenterol. |
pmid:12385435
|
Dohil R et al. |
Effective 2-wk therapy for Helicobacter pylori disease in children. |
1997 |
Am. J. Gastroenterol. |
pmid:9040199
|
Lerang F et al. |
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? |
1997 |
Am. J. Gastroenterol. |
pmid:9040200
|
Chey WD et al. |
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial. |
1997 |
Am. J. Gastroenterol. |
pmid:9317068
|
Gatta L et al. |
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. |
2009 |
Am. J. Gastroenterol. |
pmid:19844205
|
Kim CG et al. |
Preoperative versus postoperative Helicobacter pylori eradication therapy in gastric cancer patients: a randomized trial. |
2008 |
Am. J. Gastroenterol. |
pmid:17714557
|
Adamek RJ et al. |
Pantoprazole versus omeprazole in one-week low-dose triple therapy for curve of H. pylori infection. |
1997 |
Am. J. Gastroenterol. |
pmid:9382084
|
Moayyedi P and Malfertheiner P |
Editorial: Sequential therapy for eradication of Helicobacter pylori: a new guiding light or a false dawn? |
2009 |
Am. J. Gastroenterol. |
pmid:19956122
|
Zullo A et al. |
A quintuple therapy for H. pylori eradication. |
2007 |
Am. J. Gastroenterol. |
pmid:17958765
|
Schwartz H et al. |
Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. |
1998 |
Am. J. Gastroenterol. |
pmid:9576452
|
Calvet X et al. |
Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial. |
2005 |
Am. J. Gastroenterol. |
pmid:16086704
|
Park CS et al. |
Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance. |
2014 |
Am. J. Gastroenterol. |
pmid:25091062
|
Vakil N |
Helicobacter pylori treatment: a practical approach. |
2006 |
Am. J. Gastroenterol. |
pmid:16542285
|
Santander C et al. |
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. |
1996 |
Am. J. Gastroenterol. |
pmid:8759659
|
Tursi A et al. |
Short-term low-dose triple therapy with lansoprazole plus amoxycillin and clarithromycin for Helicobacter pylori eradication. |
1996 |
Am. J. Gastroenterol. |
pmid:8759696
|
Bytzer P |
Management of the dyspeptic patient: anything goes? |
2006 |
Am. J. Gastroenterol. |
pmid:16771938
|
Manes G et al. |
Eradication of Helicobacter pylori and dosages of esomeprazole. |
2006 |
Am. J. Gastroenterol. |
pmid:16771971
|
Sonnenberg A et al. |
The effect of antibiotic therapy on bleeding from duodenal ulcer. |
1999 |
Am. J. Gastroenterol. |
pmid:10201462
|
Smoot DT et al. |
Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori. |
1999 |
Am. J. Gastroenterol. |
pmid:10201463
|
Fuccio L et al. |
Can sequential therapy for Helicobacter pylori eradication overcome clarithromycin resistance?: Data still do not support conclusions. |
2010 |
Am. J. Gastroenterol. |
pmid:20606668
|
Laine L et al. |
Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. |
2000 |
Am. J. Gastroenterol. |
pmid:11151867
|
Laine L et al. |
Once-daily therapy for H. pylori infection: a randomized comparison of four regimens. |
1999 |
Am. J. Gastroenterol. |
pmid:10201465
|
Maconi G et al. |
Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? |
2001 |
Am. J. Gastroenterol. |
pmid:11232676
|
Parasakthi N and Goh KL |
Primary and acquired resistance to clarithromycin among Helicobacter pylori strains in Malaysia. |
1995 |
Am. J. Gastroenterol. |
pmid:7872306
|
Kadayifçi A et al. |
Low dose clarithromycin plus omeprazole eradicates Helicobacter pylori in duodenal ulcer disease. |
1995 |
Am. J. Gastroenterol. |
pmid:7872307
|
Nam SY et al. |
Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. |
2010 |
Am. J. Gastroenterol. |
pmid:20571493
|
Veldhuyzen van Zanten S et al. |
Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia. |
2003 |
Am. J. Gastroenterol. |
pmid:14499772
|
Luther J et al. |
Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability. |
2010 |
Am. J. Gastroenterol. |
pmid:19755966
|